Description
CJC-1295 is a synthetic peptide analog of GHRH widely studied in laboratory research focused on growth hormone regulatory signaling and endocrine pathway modulation. It serves as a research tool for examining somatotropic axis activation mechanisms.
Biochemical Characteristics
CJC-1295 is structurally derived from endogenous GHRH and designed to enhance peptide stability and receptor affinity in experimental systems. Its molecular structure supports controlled evaluation of receptor-binding dynamics and downstream intracellular signaling activation.
Research Applications
CJC-1295 is utilized in research models investigating growth hormone signaling pathways, receptor interaction kinetics, peptide stability, and endocrine feedback regulation under laboratory conditions.
Pathway / Mechanistic Context
Mechanistic research focuses on CJC-1295 interaction with GHRH receptors and activation of downstream signaling cascades associated with growth hormone synthesis and release within the somatotropic axis.
Preclinical Research Summary
Preclinical investigations have evaluated CJC-1295 in in vitro and experimental models to better understand receptor-mediated endocrine signaling and growth hormone pathway modulation.
Form & Analytical Testing
CJC-1295 is supplied as a lyophilized peptide and undergoes analytical verification, including HPLC testing, to confirm identity, purity, and composition consistency for laboratory research use.
RUO Disclaimer
This product is intended strictly for research and laboratory use only. It is not approved for human consumption, medical treatment, veterinary use, cosmetic application, or diagnostic purposes. Handling should be performed only by qualified professionals trained in proper laboratory procedures.






Reviews
There are no reviews yet.